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Inflammasome Activation in Delayed-
Type Hypersensitivity Reactions
Amir S. Yazdi1, Kamran Ghoreschi1 and Martin Röcken1
The inflammasome is a protein complex cleaving the pro-inflammatory cytokines 
IL-1β and IL-18 into their active forms by caspase-1 activation. The cytosolic pro-
tein complex can be activated by danger signals, such as bacterial and viral com-
ponents, ATP, or uric acid crystals, and reacts as a sensor of innate immunity. In 
the skin, sensitizing agents promote induction of specific T-cell-mediated contact 
hypersensitivity. They induce dendritic cell migration, a precondition for the prim-
ing of specific T cells. They are a prerequisite for the recruitment of cells into the 
skin that demand pro-inflammatory stimuli, such as IL-1β and IL-18. Watanabe et 
al. (2007, this issue) demonstrate the presence of the inflammasome complex in 
keratinocytes and report that this complex can be activated by contact sensitizers, 
such as trinitrocholorobenzene (TNCB), both in vitro and in vivo. The study docu-
ments a regulatory effect of innate immunity in a T-cell-mediated delayed-type 
hypersensitivity reaction. 
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The inflammasome is a cytosolic mul-
tiprotein complex activating caspase-1 
and caspase-5. Caspase-1 activation 
leads to the cleavage of the pro-inflam-
matory cytokines IL-1β and IL-18 into 
their active forms. Two types of inflam-
masomes have been described so far, 
the NALP1 and the NALP3 inflamma-
some. The NALP3 inflammasome is 
composed of NALP3 (NACHT, LRR, and 
pyrin domain), the adaptor protein ASC 
(apoptosis-associated specklike pro-
tein containing a caspase-recruitment 
domain), and caspase-1, and the NALP1 
inflammasome additionally contains 
caspase-5. The recognition of danger 
signals, such as pathogen-associated 
molecular patterns, leads to oligomer-
ization of NALP3 and complexation of 
the inflammasome components, thus 
inducing the proteolytic cleavage of pro-
caspase-1 into its active form. Caspase-1 
can process pro-IL-1β and pro-IL-18 to 
IL-1β and IL-18 (Martinon et al., 2002).
Gain of function mutations in the 
NALP3 gene can cause various autoin-
flammatory diseases, such as Muckle–
Wells syndrome, chronic infantile 
neurological cutaneous and articular 
disease, and familial cold urticaria. 
These disorders are characterized by 
recurrent episodes of fever and cutane-
ous, pulmonary, or articular edema and 
inflammation. Currently, the therapy of 
choice for these inflammatory diseases 
is the IL-1 receptor antagonist.
Macrophages and neutrophils con-
tain the inflammasome complex that 
secretes IL-1β upon activation by dan-
ger signals, such as lipopolysaccharide, 
adenosine triphosphate (ATP) (Ferrari et 
al., 2006), or cell injury. The activation 
of IL-1β triggers a cascade of molecular 
events that leads to inflammation.
Three recent reports using mice defi-
cient in various inflammasome compo-
nents reveal that the inflammasome is 
an entity that can assemble in a stimu-
lus-dependent matter and that secre-
tion of IL-1β can be diminished under 
inflammasome inhibitory conditions. 
Mariathasan et al. (2006) demonstrate 
that serial stimulation with Toll-like 
receptor ligands plus ATP activates the 
NALP3 inflammasome. Toll-like receptor 
ligand stimulation can induce increased 
pro-IL1β production by activation of 
NF-κB, while ATP activates the NALP3 
inflammasome by the promotion of K+ 
efflux. Mariathasan et al. further prove 
that NALP3 or ASC deficiency leads 
to impaired immune response exclu-
sively against some pathogens, such as 
Staphylococcus aureus or Listeria mono-
cytogenes, but not against others, such 
as Salmonella typhimurium. Francisella 
tularensis, on the other hand, demands 
only ASC, but not NALP3 for the induc-
tion of an immune response, whereas 
bacterial RNA and vaccine adjuvants 
activate caspase-1 in a NALP3-depen-
dent manner (Kanneganti et al., 2006).
Although these two groups presented 
multiple independent pathways that 
lead to caspase-1 activation and secre-
tion of the pro-inflammatory cytokine 
IL-1β in response to bacterial or viral 
compounds, Martinon et al. (2006) 
examined the function of key compo-
nents of the inflammasome complex 
in the detection of monosodium urate 
and calcium pyrophosphate dehydrate, 
the crystals causing joint inflammation 
in gout or pseudogout, respectively. 
These crystals function as danger signals 
and can activate caspase-1 in NALP3-
dependent matter. Interestingly, colchi-
cine, an inhibitor of tubulin polymer-
ization that is used for the treatment of 
acute gout, can block caspase activation 
induced by monosodium urate or cal-
cium pyrophosphate dehydrate but fails 
to block the activating function of ATP. 
These findings suggest microtubule for-
mation as a novel mode of caspase acti-
vation. Other crystals, such as diamond 
crystals or aluminum powder, do not act 
as inflammatory triggers in this system.
Sensitizing chemicals can penetrate 
the skin surface and have the capac-
ity to induce contact hypersensitiv-
ity reactions (CHSR), a T-cell-mediated 
delayed-type hypersensitivity reaction 
(DTHR). Dendritic cell migration, anti-
gen presentation, expansion of specific 
T cells, and recruitment of T cells to 
the skin depend on the coordinated 
interaction of inflammatory cytokines, 
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 Key components of the 
infl ammasome may 
modulate the early 
effector phase of 
T-cell-mediated 
immune responses.
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namely IL-1β and IL-18 (Shornick et 
al., 1996), which are important cyto-
kines of innate immunity, triggering 
the initiation of specific T-cell-medi-
ated immune responses. Because 
the inflammasome is one of the key 
regulators of caspase-1 activation and 
resulting IL-1β secretion, Watanabe et 
al. (Watanabe et al., 2007, this issue) 
analyzed the role of an active inflam-
masome in DTHR. They first found the 
presence of active NALP3, ASC, cas-
pase-1, caspase-5, IL-1β, and IL-18, 
key components of the inflammasome 
in keratinocytes and monocyte-derived 
cells. They found further that some 
contact sensitizers, such as trinitrochlo-
robenzene (TNCB), can act as a direct 
trigger for the activation of caspase-1, 
IL-1β, and IL-18.
Subsequently, TNCB- and 4,6-dini-
tro-1-fluorobenzene–mediated CHSR 
in wild-type, ASC-/-, and NALP3-/- mice 
was compared. Watanabe et al. report-
ed that ASC-/- and NALP3-/- mice have 
an impaired early phase reaction during 
the challenge.
These findings suggest that contact 
sensitizers such as TNCB can activate 
the inflammasome and that key com-
ponents of the inflammasome may 
modulate the early effector phase of T-
cell-mediated immune responses. The 
inflammasome can thus enhance the 
initiation of pro-inflammatory T-cell 
effector phases.
These findings contrast with a recent 
report by Sutterwala et al. (2006), who 
found that ASC-/- and NALP3-/- mice that 
were sensitized with trinitrophenylene 
chloride had a significantly impaired 
CHSR late-phase response. At 24 h, 
ASC-/- and NALP3-/- mice had almost no 
specific increase in ear swelling when 
compared with unsensitized wild-type 
mice. To determine whether NALP3 
is involved in the sensitization phase, 
splenocytes and lymph node cells from 
trinitrophenylene chloride–sensitized 
wild-type mice were transferred into 
NALP3+/+ or NALP3-/- recipients. The 
recipients of the sensitized animals 
were then challenged and ear swelling 
was measured. Interestingly, unsen-
sitized NALP3-/- mice that received 
cells from sensitized NALP3+/+ animals 
developed almost normal ear swelling, 
whereas unsensitized NALP3+/+ mice 
that received cells from sensitized 
NALP3-/- donors failed to develop ear 
swelling. This suggests that NALP3 is 
needed for the induction of antigen-
specific T-cell responses, a cell popula-
tion that is strictly required for efficient 
CHSR (Biedermann et al., 2000).
How to reconcile these two find-
ings? One theory states that the 
inflammasome complex is required 
for appropriate early phases of T-cell-
mediated inflammation (Watanabe et 
Figure 1. Structure and activation of the inflammasome. (a) NALP3 is the key central component with a 
pyrin domain (PYD) as its amino-terminal sequence, a nucleoside oligomerization domain (NOD), and a 
domain of leucine-rich repeats (LRR). Further components of the NALP3 inflammasome are the adaptor 
protein ASC (apoptosis-associated specklike protein containing a caspase-recruitment domain (CARD)) and 
pro-caspase-1. Upon activation (b) by “danger signals,” such as urate crystals or bacteria, the inflammasome 
assembles and releases active caspase-1. Activated caspase-1 cleaves pro-interleukin-1β to active IL-1β, a 
potent mediator of inflammation. ATP, adenosine triphosphate; TNCB, trinitrochlorobenzene.
Figure 2. Contact hypersensitivity reaction. (a) Sensitization with IL-1β release from keratinocytes 
and epidermal and dermal dendritic cells after TNCB detection. (b) Priming occurs after dendritic cell 
migration to the lymph node, including antigen presentation and expansion of specific T cells. This is 
supported by cytokines, such as IL-1β. After cutaneous re-exposure (c), primed T cells are recruited from 
the lymph node into the dermis and epidermis, evoking CHSR.
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al., 2007); the other theory indicates 
that this complex is required even for 
T-cell priming (Sutterwala et al., 2006).
Both systems have in common that 
obviously early innate responses are 
impaired at the level of keratinocytes, 
antigen-presenting cells, or acces-
sory cells, such as mast cells. Because 
TNCB and 4,6-dinitro-1-fluorobenzene 
are very potent in causing direct tissue 
damage, their signaling might be potent 
enough to overcome the requirement of 
the inflammasome activation for T-cell 
priming, yet at lower concentrations 
they may need the inflammasome com-
plex for T-cell priming. In the case of 
weaker stimuli, as may be the case in the 
experiments published by Sutterwala et 
al., the inflammasome complex may be 
needed to stimulate antigen-presenting 
cells in such a manner that they acquire 
the capacity to migrate to the draining 
lymph node and prime T cells for the 
establishment of CHSR.
Further characterization is needed to 
characterize the role of inflammasome-
dependent T-cell priming and its exact 
role in the effector phases of CHSR/
DTHR.
These data also raise a question 
regarding the cells involved in coordi-
nated inflammasome activation, includ-
ing keratinocytes, fibroblasts, mast cells, 
Langerhans cells, or dermal dendritic 
cells during priming and effector phas-
es. Furthermore, the exact biochemical 
characterization of inflammasome acti-
vation is needed to establish therapeu-
tic approaches capable of manipulatory 
initiation and effector functions.
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TRP-ing Up Melanophores: TRPM7, 
Melanin Synthesis, and Pigment Cell 
Survival
Aurel O. Iuga1 and Ethan A. Lerner1
McNeill et al. (2007, this issue) dissect the potential role of TRPM7 ion channels 
in pigment cells by studying the phenotype of zebrafish trpm7 mutant embryos. 
They demonstrate that 1-phenyl-2-thiourea, a known melanin synthesis inhibitor, 
prevents melanophore cell death in these mutants. This suggests a potential func-
tional link between TRPM7 signaling and the detoxification of melanin synthesis 
intermediates.
Journal of Investigative Dermatology (2007) 127, 1855–1856. doi:10.1038/sj.jid.5700773
The transient receptor potential melas-
tatin (TRPM) ion channel subfamily, one 
of the six classes of TRP channels, has 
been discovered and investigated in the 
past decade. It has a variety of functions 
from cold sensing (TRPM8) or oxida-
tive stress sensing (TRPM2) to calcium 
(TRPM4, TRPM5), magnesium (TRPM6, 
TRPM7), or osmohomeostasis (TRPM3). 
The first member discovered—TRPM1, 
or melastatin—is a tumor-suppres-
sor protein expressed at high levels in 
benign melanocytes but at low levels in 
melanoma cells with highly metastatic 
behavior (see the review by Harteneck, 
2005). The main topic of this discussion, 
TRPM7, is a ubiquitously expressed 
nonselective cation channel permeable 
for calcium, magnesium, and trace met-
als. A role for TRPM7 in pigment cell 
survival has been previously suggested 
(Elizondo et al., 2005) and is further 
investigated by McNeill et al. (2007, this 
issue).
The trpm7 zebrafish mutant was 
initially identified in a chemical muta-
genesis screen (Rawls et al., 2003; 
Arduini and Henion, 2004; Cornell et 
al., 2004). At 48 hours postfertilization 
(hpf) these mutants are lighter in color 
because they have fewer melanophores 
and altered melanophore morphol-
ogy (punctate versus stellate) as com-
pared with the wild-type phenotype. 
Surprisingly, melanophores reappear at 
72 hpf, which suggests that a compen-
satory mechanism takes place after this 
stage. In addition, the trpm7 mutants 
develop temporary touch response 
impairment during embryogenesis 
